Eli Lilly Makes Bold $1 Billion Move to Combat Opioid Crisis with SiteOne Acquisition
On May 28, 2025, Eli Lilly announced its acquisition of SiteOne Therapeutics, a privately held biopharmaceutical company, in a deal valued at up to $1 billion. This strategic move grants Eli Lilly access to STC-004, SiteOne’s experimental non-opioid pain treatment targeting Nav1.8 channels involved in pain signal transmission.
The acquisition aligns with Eli Lilly’s broader strategy to diversify its pain management portfolio beyond traditional opioids. STC-004 represents a novel approach, aiming to provide effective pain relief without the addiction risks associated with opioid therapies. This move positions Eli Lilly to further expand its footprint in the non-opioid pain relief market, addressing a significant unmet need in pain management.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
April Chemical Industry Shutdown Wave Arrives: Maintenance Plans Reflect Deep Cost Anxiety Across Enterprises
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
A $25 Billion “Mega Merger” Is Born: How the AkzoNobel × Axalta Deal Rewrites Global Coatings Power
Recommend Reading
-
![INEOS Shuts Down Europe's Last World-Scale Acetyl Production Facilities]()
INEOS Shuts Down Europe's Last World-Scale Acetyl Production Facilities
-
![Solar Industries Offers $1.355 Billion for South Africa’s Omnia in Global Mining Chemicals Expansion]()
Solar Industries Offers $1.355 Billion for South Africa’s Omnia in Global Mining Chemicals Expansion
-
![AkzoNobel Invests €50 Million to Expand Aerospace Coatings Operations in the United States]()
AkzoNobel Invests €50 Million to Expand Aerospace Coatings Operations in the United States
-
![Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition]()
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
![ExxonMobil Shuts Another Singapore Facility: The Global Petrochemical Shake-Up Leaves No Easy Winners]()
ExxonMobil Shuts Another Singapore Facility: The Global Petrochemical Shake-Up Leaves No Easy Winners
-
![Premium Global Chemical Sourcing Requests (5-9 Jan, 2026)]()
Premium Global Chemical Sourcing Requests (5-9 Jan, 2026)
-
![Business Society September 23, 2026 Fuel Oil 180CST Trend Analysis: Volatility]()
Business Society September 23, 2026 Fuel Oil 180CST Trend Analysis: Volatility
-
![China’s Propylene Oxide Market Prices Show a Significant Pullback]()
China’s Propylene Oxide Market Prices Show a Significant Pullback
-
![Business Society September 23, 2026 Petroleum Coke Trend Analysis: Volatility]()
Business Society September 23, 2026 Petroleum Coke Trend Analysis: Volatility
-
![Cost Push: Shandong Cyclohexanone Market Rises Recently]()
Cost Push: Shandong Cyclohexanone Market Rises Recently
